Email this article to a friend
Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma: evidence from an in vitro study
-
* Corresponding author: Yanhong Wang wang.yanhong@zs-hospital.sh.cn
BMC Medicine 2009, 7:41 doi:10.1186/1741-7015-7-41